|4Feb 3, 4:30 PM ET

Barry Douglas 4

4 · Tango Therapeutics, Inc. · Filed Feb 3, 2022

Insider Transaction Report

Form 4
Period: 2022-02-01
Barry Douglas
General Counsel
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-02-01+69,50069,500 total
    Exercise: $9.22Exp: 2032-02-01Common Stock (69,500 underlying)
Footnotes (1)
  • [F1]This option shall vest and become exercisable over a four-year period, at a rate of 25% on January 1, 2023, with the remaining option shares vesting in 36 equal monthly installments thereafter.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION